Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Artiva Biotherapeutics Inc ARTV

Healthcare Biotechnology
Artiva Biotherapeutics, Inc. is a clinical-stage biotechnology company. The Company is focused on developing natural killer (NK) cell-based therapies for patients suffering from devastating autoimmune diseases and cancers. Its product candidates are derived from donor cells (allogeneic) rather than a patient's own cells (autologous) and are pre-manufactured, stored frozen and ready to ship to a... see more

Current News (NDAQ:ARTV)

Artiva Biotherapeutics Announces Positive Initial Safety and Translational Data Supporting Deep B-Cell Depletion with AlloNK® in Autoimmune Disease

GlobeNewswire 4 days ago

Artiva Biotherapeutics Reports Third Quarter 2025 Financial Results and Recent Business Highlights

GlobeNewswire 4 days ago

Artiva Biotherapeutics to Host Virtual Event Discussing Initial Safety and Translational Data in up to 32 Patients with Autoimmune Disease Treated with AlloNK®

GlobeNewswire 13 days ago

Artiva Biotherapeutics to Participate in Upcoming Investor Conferences in November

GlobeNewswire October 30, 2025

Artiva Biotherapeutics Announces Refractory Rheumatoid Arthritis as Lead Indication, Upcoming Data Releases, and Corporate Update

GlobeNewswire October 16, 2025

Artiva Biotherapeutics to Participate in the Cantor Global Healthcare Conference 2025

GlobeNewswire August 25, 2025

Artiva Biotherapeutics Reports Second Quarter 2025 Financial Results, Recent Business Highlights

GlobeNewswire August 6, 2025

Artiva Biotherapeutics to Participate in the Jefferies Global Healthcare Conference

GlobeNewswire May 28, 2025

Artiva Biotherapeutics Announces Longer-term Phase 1/2 Data Demonstrating Prolonged Durability for AlloNK® in Combination with Rituximab in Patients with B-cell-Non-Hodgkin Lymphoma at the ASGCT 28th Annual Meeting

GlobeNewswire May 13, 2025
View More News ››

Opinion & Analysis (NDAQ:ARTV)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:ARTV)

Still holding this stock.

It is signalling strength to the upside today for shareholders,so good luck all of you
coolfooldumbguy - October 17, 2025

This stock is a good buy at these low prices and

It is a buy and hold position for my portfolio.
coolfooldumbguy - January 31, 2025
View more Bullboard ››

Silver North Resources Ltd.

Silver North Resources Ltd.

Silver North Resources Ltd. is a Canada-based exploration-stage company, which is focused on silver discoveries in the Keno ...
View More »